HBVAXPRO 5micrograms0.5ml vaccine suspension for injection pre-filled syringes Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

hbvaxpro 5micrograms0.5ml vaccine suspension for injection pre-filled syringes

merck sharp & dohme ltd - hepatitis b virus surface antigen - suspension for injection - 10microgram/1ml

HBVAXPRO 10micrograms1ml vaccine suspension for injection pre-filled syringes Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

hbvaxpro 10micrograms1ml vaccine suspension for injection pre-filled syringes

merck sharp & dohme ltd - hepatitis b virus surface antigen - suspension for injection - 10microgram/1ml

Engerix B 20 µg/1 ml inj. susp. s.c./i.m. pre-filled syr. Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

engerix b 20 µg/1 ml inj. susp. s.c./i.m. pre-filled syr.

glaxosmithkline biologicals sa-nv - hepatitis b virus surface antigen (recombinant) 20 µg/dose - suspension for injection - 20 µg/1 ml - hepatitis b virus surface antigen, recombinant 20 µg/dose - hepatitis b, purified antigen

Engerix B 20 µg/1 ml inj. susp. s.c./i.m. vial Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

engerix b 20 µg/1 ml inj. susp. s.c./i.m. vial

glaxosmithkline biologicals sa-nv - hepatitis b virus surface antigen (recombinant) 20 µg/dose - suspension for injection - 20 µg/1 ml - hepatitis b virus surface antigen, recombinant 20 µg/dose - hepatitis b, purified antigen

Engerix B Junior 10 µg/0.5 ml inj. susp. s.c./i.m. pre-filled syr. Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

engerix b junior 10 µg/0.5 ml inj. susp. s.c./i.m. pre-filled syr.

glaxosmithkline biologicals sa-nv - hepatitis b virus surface antigen (recombinant) 10 µg/dose - suspension for injection - 10 µg/0,5 ml - hepatitis b virus surface antigen, recombinant 10 µg/dose - hepatitis b, purified antigen

Engerix B Junior 10 µg/0.5 ml inj. susp. s.c./i.m. vial Belgija - anglų - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

engerix b junior 10 µg/0.5 ml inj. susp. s.c./i.m. vial

glaxosmithkline biologicals sa-nv - hepatitis b virus surface antigen (recombinant) 10 µg/dose - suspension for injection - 10 µg/0,5 ml - hepatitis b virus surface antigen, recombinant 10 µg/dose - hepatitis b, purified antigen

HBVaxPro Europos Sąjunga - anglų - EMA (European Medicines Agency)

hbvaxpro

merck sharp & dohme b.v.  - hepatitis b, recombinant surface antigen - hepatitis b; immunization - vaccines - 5 micrograms hbvaxpro is indicated for active immunisation against hepatitis-b-virus infection caused by all known subtypes in individuals from birth through 15 years of age considered at risk of exposure to hepatitis-b virus. the specific at-risk categories to be immunised are to be determined on the basis of the official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with hbvaxpro as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis-b infection. 10 micrograms hbvaxpro is indicated for active immunisation against hepatitis-b-virus infection caused by all known subtypes in individuals 16 years of age or more considered at risk of exposure to hepatitis-b virus. the specific at-risk categories to be immunised are to be determined on the basis of the official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with hbvaxpro as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis-b infection. 40 micrograms hbvaxpro is indicated for the active immunisation against hepatitis-b-virus infection caused by all known subtypes in predialysis and dialysis adult patients. it can be expected that hepatitis d will also be prevented by immunisation with hbvaxpro as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.,

TWINRIX JUNIOR (combined hepatitis A & hepatitis B vaccine) 0.5 mL injection pre-filled syringe thiomersal & preservative free Australija - anglų - Department of Health (Therapeutic Goods Administration)

twinrix junior (combined hepatitis a & hepatitis b vaccine) 0.5 ml injection pre-filled syringe thiomersal & preservative free

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 20 microgram/ml; hepatitis a virus antigen, quantity: 720 elisa unit/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; aluminium phosphate; polysorbate 20; water for injections; neomycin sulfate; monobasic sodium phosphate; trometamol; sodium chloride; dibasic sodium phosphate heptahydrate; formaldehyde solution; acetic acid; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate; glycine - twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years. twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years.

TWINRIX (combined hepatitis A & hepatitis B vaccine) 1 mL injection pre-filled syringe thiomersal & preservative free Australija - anglų - Department of Health (Therapeutic Goods Administration)

twinrix (combined hepatitis a & hepatitis b vaccine) 1 ml injection pre-filled syringe thiomersal & preservative free

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 20 microgram/ml; hepatitis a virus antigen, quantity: 720 elisa unit/ml - injection, suspension - excipient ingredients: trometamol; aluminium hydroxide hydrate; sodium chloride; polysorbate 20; neomycin sulfate; water for injections; formaldehyde solution; aluminium phosphate; dibasic sodium phosphate heptahydrate; monobasic sodium phosphate; acetic acid; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate; glycine - twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years. twinrix (720/20) is indicated for active immunisation against hepatitis a and hepatitis b virus infection in adults and children from 1 year of age. twinrix junior (360/10) is indicated for use in children aged 1 to 15 years.

H-B-VAX II hepatitis B vaccine recombinant 10 microgram/1mL injection pre-filled syringe (thiomersal free) Australija - anglų - Department of Health (Therapeutic Goods Administration)

h-b-vax ii hepatitis b vaccine recombinant 10 microgram/1ml injection pre-filled syringe (thiomersal free)

merck sharp & dohme (australia) pty ltd - hepatitis b surface antigen recombinant, quantity: 10 microgram/ml - injection, suspension - excipient ingredients: aluminium; borax; sodium chloride; water for injections - h-b-vax ii is indicated for immunisation against infection caused by all known subtypes of hepatitis b virus. adolescent vaccination is not necessary for children who have received a primary course of hepatitis b vaccine. vaccination is recommended in adults who ar at substantial risk of hepatitis b virus infection and have demonstrated or judged to be susceptible. vaccination of individuals who have antibodies against hepatitis b virus from a previous infection is not necessary.